Paul Blake's Net Worth

$941 Thousand

Estimate Recalculated Feb 7, 2024 03:53PM EST

Who is Paul Blake?

Paul Blake does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include VIACELL INC, CV Sciences, Inc., CEPHALON INC, and MEMORY PHARMACEUTICALS CORP.

SEC CIK

Paul Blake's CIK is 0001209719

Past Insider Trading and Trends

2005 was Paul Blake's most active year for acquiring shares with 4 total transactions. Paul Blake's most active month to acquire stocks was the month of November. 2006 was Paul Blake's most active year for disposing of shares, totalling 5 transactions. Paul Blake's most active month to dispose stocks was the month of January. 2020 saw Paul Blake paying a total of $4,992.39 for 162,801 shares, this is the most they've acquired in one year. In 2006 Paul Blake cashed out on 6,938 shares for a total of $517,016.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VIACELL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 19
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 11
No matching records found

CV Sciences, Inc. (CVSI) Snapshot price: $0.03797

Investor

Paul Blake owns 12,801 units of Common Stock which is worth $486.05. From 2019 to 2021 Paul Blake acquired a total of 12,801 shares in CV Sciences, Inc. at a cost of $4,992.39.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 16
Form 4
∞
12.8K
$0.39
$4,992.39
12.8K
May 14
Form 3
—
0
—
—
0
No matching records found

CEPHALON INC No price found

Exec VP, Clin Res & Reg Aff

Paul Blake owns 40,000 units of Common Stock. From 2003 to 2006 Paul Blake acquired a total of 55,000 shares in CEPHALON INC, Paul also disposed a total of 15,202 shares of CEPHALON INC equalling to $945,710.25.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.78%
-6.94K
$74.52
-$517,016.00
40K
Feb 17
Form 4
-6.12%
-3.06K
$56.59
-$173,278.58
46.94K
Dec 16 - Dec 19
Form 4
+42.86%
15K
—
—
50K
Dec 1
Form 4
+75.00%
15K
$49.19
-$245,956.01
35K
Dec 16 - Dec 17
Form 4
∞
20K
—
—
20K
Dec 17
Form 4
-100.00%
-202.00
$46.83
-$9,459.66
0
Nov 26
No matching records found

MEMORY PHARMACEUTICALS CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Nov 9
Form 3
—
0
—
—
0
No matching records found